Reactivity of T cells from women with antibodies to the human platelet antigen (HPA)-1a to peptides encompassing the HPA-1 polymorphism

Clinical and Experimental Immunology

Volumn 142, Issue 1, 2005, Pages 92-102

  Jackson, D J ^a   Murphy, M F ^c   Soothill, P W ^a   Lucas, G F ^b   Elson, C J ^a   Kumpel, Belinda M ^a,b  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b NHS BLOOD AND TRANSPLANT   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Anti HPA 1a; Fetal and neonatal alloimmune thrombocytopenia; HPA 1; Peptides; T cells

Indexed keywords

ALLOANTIGEN; IMMUNOGLOBULIN; LEUCINE; PEPTIDE; PLATELET ANTIGEN 1A; PLATELET ANTIGEN 1B; PROLINE; THROMBOCYTE ANTIBODY; THROMBOCYTE ANTIGEN; THYMIDINE; UNCLASSIFIED DRUG;

ALLOIMMUNITY; ANTIGEN ANTIBODY COMPLEX; ARTICLE; CELL ACTIVITY; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GENETIC POLYMORPHISM; HUMAN; HUMAN CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PREGNANCY; PRIORITY JOURNAL; T LYMPHOCYTE; THROMBOCYTOPENIA;

ANTIGENS, HUMAN PLATELET; CELL DIVISION; EPITOPES; FEMALE; HUMANS; INFANT, NEWBORN; ISOANTIBODIES; LEUKOCYTES, MONONUCLEAR; PEPTIDE FRAGMENTS; POLYMORPHISM, GENETIC; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; T-LYMPHOCYTES;

EID: 25444508419     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2005.02903.x     Document Type: Article

References (44)

1. 33 amino acid polymorphism in membrane glycoprotein IIIa and are distinguishable by DNA typing. J Clin Invest 1989; 83:1778-81.
2. Ginsberg MH, Loftus J, Ryckwaert JJ, Pierschbacher M, Pytela R, Ruoslahti E, Plow EF. Immunochemical and amino-terminal sequence comparison of two cytoadhesins indicates they contain similar or identical beta subunits and distinct alpha subunits. J Biol Chem 1987; 262:5437-40.
3. Fitzgerald LA, Poncz M, Steiner B, Rall SC Jr, Bennett JS, Phillips DR. Comparison of cDNA-derived protein sequences of the human fibronectin and vitronectin receptor alpha-subunits and platelet glycoprotein IIb. Biochemistry 1987; 26:8158-65.
4. a) as determined by antenatal screening. Blood 1998; 92:2280-7.
5. Decary F, L'Abbe D, Tremblay L, Chartrand P. The immune response to the HPA-1a antigen: association with HLA-DRw52a. Transfusion Med 1991; 1:55-62.
6. A1: evidence for heterogeneity in the humoral response. Blood 1995; 85:3028-33.
7. A alloantigens on human integrin β3. Blood 1995; 86:234-42.
8. Mueller-Eckhardt C, Kiefel V, Grubert A, Kroll H, Weisheit M, Schmidt S, Mueller-Eckhardt G, Santoso S. 348 cases of suspected neonatal alloimmune thrombocytopenia. Lancet 1989; 1:363-6.
9. Bussel JB, Zabusky MR, Berkowitz RL, McFarland JG. Fetal alloimmune thrombocytopenia. N Engl J Med 1997; 337:22-6.
10. Letsky EA, Greaves M. Guidelines on the investigation and management of thrombocytopenia in pregnancy and neonatal alloimmune thrombocytopenia. Br J Haematol 1996; 95:21-6.
11. Murphy MF, Waters AH, Doughty HA, Hambley H, Mibashan RS, Nicolaides K, Rodeck CH. Antenatal management of fetomaternal alloimmune thrombocytopenia - report of 15 affected pregnancies. Transf Med 1994; 4:281-92.
12. Bussel JB, Berkowitz RL, Lynch L, Lesser ML, Paidas MJ, Huang CL, McFarland JG. Antenatal management of alloimmune thrombocytopenia with intravenous γ-globulin. a randomised trial of the addition of low-dose steroid to intravenous γ-globulin. Am J Obstet Gynecol 1996; 174:1414-23.
13. Radder CM, Brand A, Kanhai HHH. A less invasive treatment strategy to prevent intracranial hemorrhage in fetal and neonatal alloimmune thrombocytopenia. Am J Obstet Gynecol 2001; 185:683-8.
14. Jaegtvik S, Husebekk A, Aune B, Øian P, Dahl LB, Skogen B. Neonatal alloimmune thrombocytopenia due to anti-HPA 1a antibodies; the level of maternal antibodies predicts the severity of thrombocytopenia in the newborn. Br J Obstet Gynaecol 2000; 107:691-4.
15. Kaplan C. Platelet alloimmunity: the fetal/neonatal alloimmune thrombocytopenia. Vox Sang 2002; 83 (Suppl. 1):289-91.
16. Birchall JE, Murphy MF, Kaplan C, Kroll H. European Fetomaternal Alloimmune Thrombocytopenia Study Group. European collaborative study of the antenatal management of feto-maternal alloimmune thrombocytopenia. Br J Haematol 2003; 122:275-88.
17. Guermonprez P, Valladeau J, Zitvogel L, Théry C, Amigorena S. Antigen presentation and T cell stimulation by dendritic cells. Ann Rev Immunol 2002; 20:621-67.
18. Wu S, Maslanka K, Gorski J. An integrin polymorphism that defines reactivity with alloantibodies generates an anchor for MHC II peptide binding: a model for unidirectional alloimmune responses. J Immunol 1997; 158:3221-6.
19. Lucas GF, Hamon M, Carroll S, Soothill P. Effect of IVIgG treatment on fetal platelet count, HPA-1a titre and clinical outcome in a case of feto-maternal alloimmune thrombocytopenia. Br J Obstet Gynaecol 2002; 109:1195-8.
20. Montemagno R, Soothill PW, Scarcelli M, O'Brien P, Rodeck CH. Detection of alloimmune thrombocytopenia as cause of isolated hydrocephalus by fetal blood sampling. Lancet 1994; 343:1300-1.
21. Cavanagh G, Dunn AN, Chapman CE, Metcalfe P. HPA genotyping by PCR sequence-specific priming (PCR-SSP): a streamlined method for rapid routine investigations. Transfus Med 1997; 7:41-5.
22. von dem Borne AEG Kr, Verheught FWA, Oosterhof F, von Riesz E, Brutel de la Riviere A, Engelfriet CP. A simple immunofluorescence test for the detection of platelet antibodies. Br J Haematol 1978; 39:195-207.
23. Kiefel V, Santoso S, Weisheit M, Mueller-Eckhardt C. Monoclonal antibody-specific immobilization of platelet antigens (MAIPA). a new tool for the identification of platelet-reactive antibodies. Blood 1987; 70:1722-6.
24. Plebanski M, Burtles SS. In vitro primary responses of human T cells to soluble protein antigens. J Immunol Meths 1994; 170:15-25.
25. Jackson DJ, Elson CJ, Kumpel BM. Reduction of human anti-tetanus toxoid antibody in hu-PBL-SCID mice by immunodominant peptides of tetanus toxoid. Clin Exp Immunol 2004; 137:245-52.
26. Cooper N, Heddle NM, de Haas M, Reid ME, Lesser ML, Fleit HB, Woloski BMR, Bussel JB. Intravenous (IV) anti-D and IV immunoglobulin achieve acute platelet increases by different mechanisms: modulation of cytokine and platelet responses to IV anti-D by FcγRIIa and FcγRIIIa polymorphisms. Br J Haematol 2004; 124:511-8.
27. Wolf-Levin R, Aoki K, Azuma T, Yagami Y, Okada H. Human pregnancy serum suppresses the proliferative response of lymphocytes to autologous PHA-activated T lymphocytes. Am J Reprod Immunol 1996; 35:63-9.
28. Langer-Gould A, Garren H, Slansky A, Ruiz PJ, Steinman L. Late pregnancy suppresses relapses in experimental autoimmune encephalomyelitis: evidence for a suppressive pregnancy-related serum factor. J Immunol 2002; 169:1084-91.
29. Thompson SJ, Hitsumoto Y, Zhang YW, Rook GA, Elson CJ. Agalactosyl IgG in pristane-induced arthritis. Pregnancy affects the incidence and severity of arthritis and the glycosylation status of IgG. Clin Exp Immunol 1992; 89:434-8.
30. Confavreux C, Hutchinson M, Hours MM, Cortinovis-Tourniaire P, Moreau T. Rate of pregnancy-related relapse in multiple sclerosis. Pregnancy in Multiple Sclerosis Group. N Eng J Med 1998; 339:285-91.
31. Raychaudhuri SP, Navare T, Gross J, Raychaudhuri SK. Clinical course of psoriasis during pregnancy. Int J Dermatol 2003; 42:518-20.
32. Ostensen M, Villiger PM. Immunology of pregnancy - pregnancy as a remission inducing agent in rheumatoid arthritis. Transpl Immunol 2002; 9:155-60.
33. Sicotte NL, Liva SM, Klutch R, Pfeiffer P, Bouvier S, Odesa S, Wu TC, Voskuhl RR. Treatment of multiple sclerosis with the pregnancy hormone estriol. Ann Neurol 2002; 52:421-8.
34. Song XY, Zeng L, Jin W, Pilo CM, Frank ME, Wahl SM. Suppression of streptococcal cell wall-induced arthritis by human chorionic gonadotropin. Arth Rheum 2000; 43:2064-72.
35. Pender MP, Csurhes PA, Greer JM et al. Surges of increased T cell reactivity to an encephalitogenic region of myelin proteolipid protein occur more often in patients with multiple sclerosis than in healthy subjects. J Immunol 2000; 165:5322-31.
36. Mazza G, Ponsford M, Lowrey P, Campbell MJ, Zajicek J, Wraith DC. Diversity and dynamics of the T-cell response to MBP in DR2+VC individuals. Clin Exp Immunol 2002; 128:538-47.
37. Santambrogio L, Sato AK, Fischer FR, Dorf ME, Stern LJ. Abundant empty class II MHC molecules on the surface of dendritic cells. Proc Natl Acad Sci USA 1999; 96:15050-5.
38. A2). Hum Immunol 1992; 34:253-6.
39. Braud V, Valentin N, Choppin J, Cesbron A, Bignon JD, Blanchard D, Muller JY. Lack of binding of peptides carrying the human platelet antigen 1 (HPA-1) dimorphism to purified HLA-DRw52a molecules. Rev Franc Transf Hemobiol 1993; 36:439-49.
40. Urbaniak S, Sukati H, Bessos H, Barker R. HPA-1a synthetic peptides which stimulate helper T-cell responses in HPA-1a negative women alloimmunised during pregnancy. Platelets 2004; 15:272.
41. Karachunski PI, Ostlie NS, Okita DK, Conti-Fine BM. Prevention of experimental myasthenia gravis by nasal administration of synthetic acetylcholine receptor T epitope sequences. J Clin Invest 1997; 100:3027-35.
42. Burkhart C, Liu GY, Anderton SM, Metzler B, Wraith DC. Peptide-induced T cell regulation of experimental autoimmune encephalomyelitis: a role for IL-10. Int Immunol 1999; 11:1625-34.
43. Shen CR, Youssef R, Devine A, Bowie L, Hall AM, Wraith DC, Elson CJ, Barker RN. Peptides containing a dominant T-cell epitope from red cell Band 3 have in vivo immunomodulatory properties in NZB mice with autoimmune haemolytic anaemia. Blood 2003; 102:3800-6.
44. Hoyne GF, O'Hehir RE, Wraith DC, Thomas WR, Lamb JR. Inhibition of T cell and antibody responses to house dust mite allergen by inhalation of the dominant T cell epitope in naive and sensitized mice. J Exp Med 1993; 178:1783-8.